Pancreatic Cancer Trial Results
Gemcitabine after Pancreatic Cancer Surgery Improves Survival
(Posted: 06/24/2008, Updated: 10/19/2011) - Patients who received the chemotherapy drug gemcitabine after surgery for pancreatic cancer lived two months longer than patients who had surgery alone, according to findings presented at the 2008 ASCO meeting in Chicago.
Chemotherapy Regimen Extends Survival in Advanced Pancreatic Cancer Patients
(Posted: 06/07/2011) - A four-drug chemotherapy regimen has produced the longest improvement in survival ever seen in a phase III clinical trial of patients with metastatic pancreatic cancer, one of the deadliest types of cancer.
Targeted Therapies May Be Effective Against Rare Pancreatic Cancer
(Posted: 04/08/2011) - In two phase III clinical trials published February 9, 2011, in the New England Journal of Medicine (NEJM), the targeted therapies sunitinib and everolimus improved outcomes for patients with pancreatic neuroendocrine tumors.
Can Aspirin Reduce Cancer Risk and Mortality?
(Posted: 03/30/2011) - A meta-analysis of eight clinical trials involving regular aspirin use showed a substantial reduction in mortality for a number of different cancers.
(Posted: 06/24/2008, Updated: 10/19/2011) - Patients who received the chemotherapy drug gemcitabine after surgery for pancreatic cancer lived two months longer than patients who had surgery alone, according to findings presented at the 2008 ASCO meeting in Chicago.
Chemotherapy Regimen Extends Survival in Advanced Pancreatic Cancer Patients
(Posted: 06/07/2011) - A four-drug chemotherapy regimen has produced the longest improvement in survival ever seen in a phase III clinical trial of patients with metastatic pancreatic cancer, one of the deadliest types of cancer.
Targeted Therapies May Be Effective Against Rare Pancreatic Cancer
(Posted: 04/08/2011) - In two phase III clinical trials published February 9, 2011, in the New England Journal of Medicine (NEJM), the targeted therapies sunitinib and everolimus improved outcomes for patients with pancreatic neuroendocrine tumors.
Can Aspirin Reduce Cancer Risk and Mortality?
(Posted: 03/30/2011) - A meta-analysis of eight clinical trials involving regular aspirin use showed a substantial reduction in mortality for a number of different cancers.